Drug Profile
Forasartan
Alternative Names: SC 52458Latest Information Update: 09 Oct 2001
Price :
$50
*
At a glance
- Originator Pharmacia Corporation
- Class Antihypertensives; Pyridines; Small molecules; Tetrazoles
- Mechanism of Action Angiotensin type 1 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Hypertension
Most Recent Events
- 09 Oct 2001 No-Development-Reported for Hypertension in European Union (PO)
- 09 Oct 2001 No-Development-Reported for Hypertension in Japan (PO)
- 09 Oct 2001 No-Development-Reported for Hypertension in USA (PO)